Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000950134-09-003728
Filing Date
2009-02-25
Accepted
2009-02-25 17:14:28
Documents
7
Period of Report
2008-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K f51516e10vk.htm 10-K 1058453
2 EX-10.27 f51516exv10w27.htm EX-10.27 270484
3 EX-23.1 f51516exv23w1.htm EX-23.1 10208
4 EX-31.1 f51516exv31w1.htm EX-31.1 7283
5 EX-31.2 f51516exv31w2.htm EX-31.2 7311
6 EX-32.1 f51516exv32w1.htm EX-32.1 4799
7 GRAPHIC f51516f5151601.gif GRAPHIC 14972
  Complete submission text file 0000950134-09-003728.txt   1380721
Mailing Address 2100 POWELL STREET EMERYVILLE CA 94608
Business Address 2100 POWELL STREET EMERYVILLE CA 94608 5105976500
ONYX PHARMACEUTICALS INC (Filer) CIK: 0001012140 (see all company filings)

EIN.: 943154463 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-28298 | Film No.: 09634668
SIC: 2836 Biological Products, (No Diagnostic Substances)